CT
Catherine T. Doherty sold $5.5M of DGX stock
Catherine T. Doherty, Executive Vice President of Quest Diagnostics Inc (DGX), sold 22,105 shares of DGX stock worth $5.5M, per an SEC Form 4 filed Nov 6, 2026.
The sale was pre-arranged (a 10b5-1 plan or an option exercise), not a fresh decision.
The trade happened on Nov 3, 2026, 3 days before it was made public.
DGX has moved +3.5% since the trade date, from $247.06 to $255.63 (Nov 6, 2026 close).
- Traded
- Nov 3, 2026
- Disclosed
- Nov 6, 2026
- Filing delay
- 3 days
- Price since
- +3.5%
- Role
- Executive Vice President
- Source
- SEC Form 4